Correlation Between Fortress Biotech and Mereo BioPharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fortress Biotech and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fortress Biotech and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fortress Biotech and Mereo BioPharma Group, you can compare the effects of market volatilities on Fortress Biotech and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fortress Biotech with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fortress Biotech and Mereo BioPharma.

Diversification Opportunities for Fortress Biotech and Mereo BioPharma

0.6
  Correlation Coefficient

Poor diversification

The 3 months correlation between Fortress and Mereo is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Fortress Biotech and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and Fortress Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fortress Biotech are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of Fortress Biotech i.e., Fortress Biotech and Mereo BioPharma go up and down completely randomly.

Pair Corralation between Fortress Biotech and Mereo BioPharma

Given the investment horizon of 90 days Fortress Biotech is expected to under-perform the Mereo BioPharma. In addition to that, Fortress Biotech is 1.32 times more volatile than Mereo BioPharma Group. It trades about -0.02 of its total potential returns per unit of risk. Mereo BioPharma Group is currently generating about 0.08 per unit of volatility. If you would invest  80.00  in Mereo BioPharma Group on August 29, 2024 and sell it today you would earn a total of  260.00  from holding Mereo BioPharma Group or generate 325.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Fortress Biotech  vs.  Mereo BioPharma Group

 Performance 
       Timeline  
Fortress Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fortress Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Fortress Biotech is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Mereo BioPharma Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Fortress Biotech and Mereo BioPharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fortress Biotech and Mereo BioPharma

The main advantage of trading using opposite Fortress Biotech and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fortress Biotech position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.
The idea behind Fortress Biotech and Mereo BioPharma Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing